Thyroid Artery Embolization for the Treatment of Compressive Goiters.
Thyroid Artery Embolization for the Treatment of Compressive Goiters: a Prospective Cohort Study.
Université de Sherbrooke
20 participants
Jan 31, 2026
INTERVENTIONAL
Conditions
Summary
Very few studies have investigated TAE as a treatment for goiter with compressive symptoms. What is the efficacy and safety of TAE for the treatment of compressive goiters in a population ineligible for or refusing standard therapy? This is a prospective interventional cohort study that will allow us to standardize imaging by improving quality data collection and fellow-up to assess the efficacy of TAE for compressive symptoms of nodular goiters. Not only to corroborate current emerging results but clearly define the expected results for this technique.
Eligibility
Inclusion Criteria5
- Patient with compressive symptoms or significant tracheal or oesophageal compression at risk of causing symptoms attributed to a goiter AND
- Ineligible for surgery/ablative treatments or preference for TAE over other treatments AND
- TiRADS category 1, 2, 3 or 4 AND
- Bethesda categories I or III on 2 different biopsies OR Bethesda II on one biopsy AND
- Patient at least 18 years old.
Exclusion Criteria6
- Comorbidities precluding endovascular procedure OR
- TiRADS category 5 OR
- Bethesda categories IV, V, VI on biopsy OR
- Refusal of the patient to participate OR
- Uncontrolled severe hyperthyroidism OR
- Minor patient.
Interventions
Interruption of blood flow that supplies thyroid nodule using embolization technique.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07360587